Market research reports, consulting: Global Market Insights Inc.
We use cookies to enhance user experience. (Privacy Policy)

Pharmaceutical Cartridges Market Analysis

Report ID: GMI9223
   |
Published Date: April 2024
 | 
Report Format: PDF

Download free sample

Pharmaceutical Cartridges Market Analysis

Pharmaceutical Cartridges Market, By Component, 2021 – 2032 (USD Billion)

Based on the components, the global market is classified into plungers, vials, and seals. The vials segment has asserted its dominance in the global market by securing a significant share and experiencing growth of 7.2% between 2024 - 2032.
 

  • Glass vial cartridges exhibit lowest coefficient of expansion and demonstrate high levels of thermal shock and stress tolerance. They are resilient to damage from various substances and exhibit minimal leaching due to their high melting point.
     
  • Therefore, they boast compatibility with a diverse array of pens and auto-injectors commonly employed for drug administration, spanning applications such as local dental anesthesia and insulin delivery for individuals with diabetes.
     

Pharmaceutical Cartridges Market, By Type (2023)

Based on the type, the pharmaceutical cartridges market is classified into dual chamber cartridges and large-volume cartridges. The dual chamber cartridges segment held the largest market share of 64.3% in 2023.
 

  • Dual chamber cartridges are commonly used for reconstituting pharmaceuticals, especially for delicate substances such as certain vaccines, biologics, and hormone therapies. The prevalence of these sensitive drug formulations has steadily risen and is expected to continue growing, posing challenges in terms of shelf-life stability.
     
  • In addition, the dual chamber cartridges offered several benefits in pharmaceutical administration, including compatibility with various injection devices, accelerated time-to-market, efficient administration with fewer preparatory steps, increased patient safety, enhanced dose accuracy, and flexibility for single or multidose applications. Thus, aforementioned factors associated with dual chamber cartridges are expected to drive market growth in the coming years.
     

Based on the capacity, the pharmaceutical cartridges market is classified into 0.5 ml, 1.8 ml, 2 ml to 2.5 ml, 3 ml, 5 ml, and more than 10 ml. The 3 ml segment is expected to reach USD 1.2 billion by 2032.
 

  • The 3 mL cartridges are frequently employed for treatments necessitating a small volume delivery, including specific hormone therapies, anticoagulants, and other biologics.
     
  • The key advantage of 3 mL cartridges is their potential to minimize the frequency of injections required for administering a specified medication dose, particularly advantageous for patients needing frequent injections. For instance, small-volume cartridges are commonly used in insulin pen injectors, which are preferred by many patients due to their ease of use and portability.
     
  • Similarly, Cartridge kits such as Pii's 3 ml variant accommodate therapies demanding variable doses and frequent injections. Thus, widespread usage of 3ml capacity of cartridges among healthcare setting or diabetic patient will spur the market growth.
     

Based on the usage device, the pharmaceutical cartridges market is classified into pen injectors, autoinjectors, wearable injectors, and other usage devices. The pen injectors segment leads the market accounting for the largest revenue of USD 905.7 million and is projecting its dominance throughout the forecast period.
 

  • A pen injector cartridge is a medical device utilized for delivering medication via a pen-like apparatus. It comprises a cartridge containing the medication and a delivery mechanism enabling injection into the body.
     
  • Companies are prioritizing the development and manufacturing of pen injector cartridges that are safe, efficient, and user-friendly to cater to patient and healthcare provider needs. For instance, in February 2023, Phillips-Medisize, a subsidiary of Molex specializing in MedTech devices, diagnostic tools, and drug delivery devices, expanded its product line with a disposable pen injector. This initiative is expected to enhance platform capabilities, broaden the product portfolio, thereby propelling the segment growth in the foreseeable future.
     

Based on the application, the pharmaceutical cartridges market is classified into dental care, diabetes care, neurology, cardiology, oncology, and other applications. The diabetes care segment is poised to dominate the global market, with an anticipated growth of 7.4% during the analysis period.
 

  • Pharmaceutical cartridges play a vital role in administering insulin through specialized devices. Thus, advancements in these delivery mechanisms significantly influence the market, especially as insulin pens and pumps rely on prefilled cartridges for controlled insulin dispensation in diabetes care.
     
  • Also, key companies are focusing on strategic alliances such as acquisitions and mergers to enrich their diabetes management product range. For instance, in January 2023, Tandem Diabetes Care, Inc. acquired AMF Medical SA, aiming to enhance its diabetes management offerings with innovative solutions including its Sigi Patch Pump. Utilizing prefilled insulin cartridges, the Sigi Patch Pump simplified diabetes management, in the developmental stage. Such initiatives by companies in the pharmaceutical field is expected to augment the market growth.
     

Based on the end-user, the pharmaceutical cartridges market is categorized into hospitals, specialty clinics, ambulatory surgical centers, and other end-users. The hospitals segment accounted for 33.1% market share in 2023 and is expected to reach USD 1.3 billion by the end of 2032.
 

  • The hospital segment emerged as the dominant force in the market due to its extensive usage of injectable medications for various medical procedures and treatments.
     
  • Hospitals rely heavily on cartridges for the precise administration of drugs to patients, ensuring accurate dosing and patient safety.
     
  • Additionally, hospitals often handle a large volume of patients requiring injectable therapies, further driving the demand for pharmaceutical cartridges. This widespread utilization within hospital settings solidified the segment's dominance in the market.

 

North America Pharmaceutical Cartridges Market, 2021 – 2032 (USD Million)

North America is projected to maintain its lead in the global pharmaceutical cartridges market, anticipated to reach USD 1.3 billion by 2032.
 

  • Increasing demand for drugs and precise delivery systems is a significant growth driver. This is influenced by the prevalence of chronic diseases, a growing aging population, and technological advancements. For instance, cancer ranks as the second leading cause of mortality in the U.S., with an estimated 1.95 million new cases projected for 2023. Thus, usage of cartridges in cancer management along with substantial R&D investments by key players especially in pharmaceutical innovation for novel drug delivery devices is expected to supplement the region’s dominance in the market.
Authors: Mariam Faizullabhoy, Gauri Wani
Frequently Asked Question(FAQ) :
Why is the demand for dual chamber pharmaceutical cartridges rising?
The dual chamber cartridges type segment held 64.3% of the market share in 2023 and will expand rapidly till 2032, owing to its benefits in pharmaceutical administration, including compatibility with various injection devices.
How much is the pharmaceutical cartridges industry worth?
Why are pharmaceutical cartridges preferred in North America?
Who are the major global pharmaceutical cartridges industry players?
Pharmaceutical Cartridges Market Scope

Report Content

Chapter 1   Methodology & Scope

1.1    Market scope & definitions

1.2    Research design

1.2.1   Research approach

1.2.2   Data collection methods

1.3    Base estimates & calculations

1.3.1   Base year calculation

1.3.2   Key trends for market estimation

1.4    Forecast model

1.5    Primary research and validation

1.5.1   Primary sources

1.5.2   Data mining sources

Chapter 2   Executive Summary

2.1    Industry 360º synopsis

Chapter 3   Industry Insights

3.1    Industry ecosystem analysis

3.2    Industry impact forces

3.2.1   Growth drivers

3.2.1.1   Rising demand for easy-to-use and convenient pharmaceutical packaging solutions

3.2.1.2   Growing advances in pharmaceutical drug delivery and manufacturing technology

3.2.1.3   Increasing focus on biologics and the trend towards personalized medicine

3.2.2    Industry pitfalls & challenges

3.2.2.1    Manufacturing complexity

3.2.2.2    Stringent regulatory framework

3.3    Growth potential analysis

3.4    Regulatory landscape

3.5    Porter’s analysis

3.6    PESTEL analysis

Chapter 4   Competitive Landscape, 2023

4.1    Introduction

4.2    Company matrix analysis

4.3    Competitive analysis of major market players

4.4    Competitive positioning matrix

4.5    Strategic dashboard

Chapter 5   Market Estimates and Forecast, By Component, 2021 - 2032 ($ Million)

5.1    Key trends

5.2    Plungers

5.2.1   Chlorinated butyl rubber

5.2.2   Bromobutyl rubber

5.3    Vials

5.3.1   Glass

5.3.1.1    Type 1

5.3.1.2    Type 2

5.3.1.3    Type 3

5.3.2   Plastic

5.3.2.1    Polypropylene (PP)

5.3.2.2    Cyclic olefin copolymer (COC)

5.3.2.3    Cyclic olefin polymer (COP)

5.3.2.4    Polyethylene

5.3.2.5    Other plastic vials

5.4    Seals

Chapter 6   Market Estimates and Forecast, By Type, 2021 - 2032 ($ Million)

6.1    Key trends

6.2    Dual chamber cartridges

6.3    Large-volume cartridges

Chapter 7   Market Estimates and Forecast, By Capacity, 2021 - 2032 ($ Million)

7.1    Key trends

7.2    0.5 ml

7.3    1.8 ml

7.4    2ml to 2.5 ml

7.5    3 ml

7.6    5 ml

7.7    More than 10 ml

Chapter 8   Market Estimates and Forecast, By Usage Device, 2021 - 2032 ($ Million)

8.1    Key trends

8.2    Pen injectors

8.3    Autoinjectors

8.4    Wearable injectors

8.5    Other usage devices

Chapter 9   Market Estimates and Forecast, By Application, 2021 - 2032 ($ Million)

9.1    Key trends

9.2    Dental care

9.3    Diabetes care

9.4    Neurology

9.5    Cardiology

9.6    Oncology

9.7    Other applications

Chapter 10   Market Estimates and Forecast, By End-user, 2021 - 2032 ($ Million)

10.1    Key trends

10.2    Hospitals

10.3    Specialty clinics

10.4    Ambulatory surgical centers

10.5    Homecare settings

10.6    Other end-users

Chapter 11   Market Estimates and Forecast, By Region, 2021 - 2032 ($ Million)

11.1    Key trends, by region

11.2    North America

11.2.1   U.S.

11.2.2   Canada

11.3    Europe

11.3.1   Germany

11.3.2   UK

11.3.3   France

11.3.4   Spain

11.3.5   Italy

11.3.6   Rest of Europe

11.4    Asia Pacific

11.4.1   Japan

11.4.2   China

11.4.3   India

11.4.4   Australia

11.4.5   Rest of Asia Pacific

11.5    Latin America

11.5.1   Brazil

11.5.2   Mexico

11.5.3   Rest of Latin America

11.6    Middle East and Africa

11.6.1   South Africa

11.6.2   Saudi Arabia

11.6.3   Rest of Middle East and Africa

Chapter 12   Company Profiles

12.1    AptarGroup, Inc.

12.2    Baxter International Inc.

12.3    Dätwyler Holding Inc.

12.4    Gerresheimer AG

12.5    Merck KGaA

12.6    Nipro Corporation

12.7    Schott Group

12.8    Shandong Medicinal Glass Co., Ltd.

12.9    Stevanato Group

12.10   Transcoject GmbH

12.11   West Pharmaceutical Services, Inc.

12.12   Ypsomed AG

   

Authors: Mariam Faizullabhoy, Gauri Wani
Buy Now
$4,123 $4,850
15% off
$4,280 $5,350
20% off
$5,845 $8,350
30% off
    Buy now
Premium Report Details

Base Year: 2023

Companies covered: 12

Tables & Figures: 349

Countries covered: 19

Pages: 200

Download Free Sample

Top